WBA

WBA Stock

WBA (WBA) stock. Drillr has 2 published research articles covering WBA.

WBA research & analysis

  1. FTC Insulin Crackdown: CVS Settles — What It Means for LLY, NVO, and WBA

    CVS Health's recent settlement with the FTC over insulin pricing marks a pivotal moment in the pharmaceutical landscape. This article analyzes the potential winners and losers among pharmacies and drugmakers as regulatory scrutiny intensifies, highlighting key players like Eli Lilly, Novo Nordisk, and Walgreens Boots Alliance.

    CVSLLYNVO
  2. Pharma Tariffs: LLY, TMO, CVS Supply Chain Exposure Ranked by Risk

    Trump's April 2 pharma tariff announcement highlights supply chain risks for LLY, TMO, and CVS, with SEC filings exposing China reliance. Stocks dipped mildly, but domestic manufacturing offers protection amid margin pressures.

    PFEMRKLLY

Track WBA with Drillr

SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.

Try Drillr for free